Crispr Therapeutics shares owned by Congress Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Congress Asset Management
from 13F filings
Historical chart of Congress Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Congress Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.4M | 65k | 68.16 |
| 2023-12-31 | $2.5M | 40k | 62.60 |
| 2023-09-30 | $1.8M | 40k | 45.39 |
| 2020-12-31 | $2.6M | 17k | 153.10 |
| 2020-09-30 | $1.4M | 17k | 83.63 |
| 2020-06-30 | $1.2M | 17k | 73.46 |
| 2020-03-31 | $685k | 16k | 42.41 |
| 2019-12-31 | $984k | 16k | 60.93 |
| 2019-09-30 | $1.8M | 43k | 40.98 |
| 2019-06-30 | $2.0M | 43k | 47.11 |
| 2019-03-31 | $699k | 20k | 35.74 |